HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 157-168 of 4,505
Other study type icon
RecruitingNCT07419321

Social Isolation and Aging in Schizophrenia

Official study title

The Impact of Social Isolation on Aging Health in Schizophrenia

Multiple locations, including Hartford
SchizophreniaObservational studyAges 40–70
Countries
United States, United Kingdom, Netherlands, + 1 other
Sponsor
Icahn School of Medicine at Mount Sinai
Drug study icon
RecruitingNCT06502964

ALTO-101 in people with Schizophrenia

Official study title

Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 21–55
Countries
United States
Sponsor
Alto Neuroscience
Drug study icon
RecruitingNCT07565428

Roluperidone for schizophrenia

What is this study about?

This study evaluates the effectiveness of Roluperidone for people with schizophrenia.

Multiple locations, including Bellflower
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Minerva Neurosciences
Drug study icon
RecruitingNCT07363577

LB-102 for schizophrenia

Official study title

A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Efficacy and Safety of LB 102 in the Treatment of Adult Patients With Acute Schizophrenia

Multiple locations, including Bentonville
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
LB Pharmaceuticals Inc.
Drug study icon
RecruitingNCT05958875

Effect of a Six Week Intensified Pharmacological Treatment for schizophrenia

What is this study about?

Researchers are comparing Clozapine and Second-line Antipsychotics (treatment as usual) to find out how the approaches affect psychotic symptoms in people with schizophrenia.

Multiple locations, including Innsbruck
SchizophreniaMedication studyAges 18–70
Countries
United Kingdom, Austria, Germany, + 2 others
Sponsor
Dr. Inge Winter
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.